Singapore markets close in 6 hours 28 minutes

Santen Pharmaceutical Co., Ltd. (SNPHF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
10.180.00 (0.00%)
At close: 09:57AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.75B
Enterprise value 3.15B
Trailing P/E 22.21
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.96
Price/book (mrq)1.91
Enterprise value/revenue 1.63
Enterprise value/EBITDA 9.73

Trading information

Stock price history

Beta (5Y monthly) 0.25
52-week change 37.19%
S&P500 52-week change 321.45%
52-week high 310.60
52-week low 38.46
50-day moving average 39.84
200-day moving average 39.54

Share statistics

Avg vol (3-month) 377
Avg vol (10-day) 330
Shares outstanding 5363.21M
Implied shares outstanding 6365.54M
Float 8348.73M
% held by insiders 12.79%
% held by institutions 149.63%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.22
Forward annual dividend yield 42.13%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 42.11
Payout ratio 445.60%
Dividend date 327 Jun 2018
Ex-dividend date 427 Sept 2024
Last split factor 25:1
Last split date 327 Mar 2015

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024


Profit margin 8.82%
Operating margin (ttm)3.01%

Management effectiveness

Return on assets (ttm)5.62%
Return on equity (ttm)8.92%

Income statement

Revenue (ttm)301.96B
Revenue per share (ttm)823.04
Quarterly revenue growth (yoy)-0.20%
Gross profit (ttm)N/A
Net income avi to common (ttm)26.64B
Diluted EPS (ttm)0.46
Quarterly earnings growth (yoy)-97.40%

Balance sheet

Total cash (mrq)94.96B
Total cash per share (mrq)261.62
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.55
Book value per share (mrq)843.19

Cash flow statement

Operating cash flow (ttm)72.65B
Levered free cash flow (ttm)50.53B